Navigation Links
QB3 signs agreement to accelerate innovation

The California Institute for Quantitative Biosciences (QB3) has signed an agreement with the Johnson & Johnson Corporate Office of Science and Technology (COSAT) to fund University of California proof-of-concept research that brings innovative science to market.

This agreement, along with the Rogers Family Foundation of Oakland, helps fund QB3's "Bridging-the-Gap" program, initiated in 2008 to support scientific projects that have high commercial potential led by faculty at UCSF, UC Berkeley and UC Santa Cruz. These awards are intended to address the critical gap between federal funding for basic research and investments in product development. Each award typically provides $250,000 over two years for research.

Former award-winning projects include a prototype of an artificial kidney developed by Shuvo Roy, UCSF professor of bioengineering and therapeutic sciences, and an automated technique to improve prostate cancer screening, invented by Amy Herr, UC Berkeley associate professor of bioengineering.

The agreement establishes the JJSI-QB3 Awards as a component of the "Bridging-the-Gap" program and calls for annual awards over the next three years. QB3 will provide the awarded projects with services from the QB3 Startup-In-A-Box program, and potentially find space in the QB3 incubator.

"This agreement is an innovative academic-industry partnership model specifically focused on startup formation," said Neena Kadaba, QB3's director of industry alliances. "These awards are designed to provide a crucial amount of pre-commercial support to help would-be entrepreneurs address potential scientific risks in their technology before launching a company."

The nine projects funded by QB3's "Bridging-the-Gap" program to date already have resulted in five new companies and three licenses to existing firms. The five companies formed in the past two years have raised over $9 million in private and public commercial funding.

"This agreement represents an important initiative for QB3 by providing additional opportunities for innovative researchers at our universities to create companies of value," said Regis Kelly, director of QB3.


Contact: Kristen Bole
University of California - San Francisco

Related biology news :

1. Hold the phone for vital signs
2. Wiley-Blackwell signs three new international open access agreements
3. Wireless network in hospital monitors vital signs
4. Reclamation signs research agreement to improve quagga and zebra mussel larvae detection
5. MU signs $5 million agreement with Coulter Translational Research Partnership Program
6. Epitomics Signs Agreement With Bayer for Antibody Technology
7. Young graphite in old rocks challenges the earliest signs of life
8. 5-minute screen identifies subtle signs of autism in 1-year olds
9. New test shows promise for detecting warning signs of joint replacement failure
10. Study provides new tool to monitor coral reef vital signs
11. Eurofins MWG Operon signs contract to supply DNA sequencing services to Research Councils
Post Your Comments:
(Date:10/29/2015)... YORK , Oct. 29, 2015 ... technology, announced a partnership with 2XU, a global ... to deliver a smart hat with advanced bio-sensing ... and other athletes to monitor key biometrics to ... the strategic partnership, the two companies will bring together ...
(Date:10/27/2015)... October 27, 2015 Munich, ... Gaze Mapping technology (ASGM) automatically maps data from mobile ... Glasses , so that they can be quantitatively ... Munich, Germany , October 28-29, 2015. ... data from mobile eye tracking videos created with ...
(Date:10/26/2015)... 26, 2015 ... adds Biometrics Market Shares, Strategies ... well as Emerging Biometrics Technologies: Global ... its collection of IT and Telecommunications ... --> . ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... - BioAmber Inc. (NYSE: BIOA ), a leader in renewable ... Act on Climate Pledge, alongside more than 140 companies from ... Administration to demonstrate an ongoing commitment to climate action and ... Paris climate negotiations. ... . --> BioAmber uses biotechnology to convert ...
(Date:11/30/2015)... , Nov. 30, 2015  Culprits beware, a ... chemistry professor Jan Halámek, is taking crime scene ...   -->   ... --> --> ... have discovered a straightforward concept for identifying whether ...
(Date:11/30/2015)... Nov. 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or ... Norman C.W. Wong to its Board of Directors to ... Zenith with a wealth of experience as co-founder of Resverlogix, ... --> --> Dr. Wong ... board of directors. Zenith,s long standing expertise in epigenetics and ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... new globally touring exhibition Jurassic World: The Exhibition, opening in March 2016 at ... embark on a worldwide tour including several North American tour dates. The Exhibition ...
Breaking Biology Technology: